A Novel Therapeutic Approach to Treat Chronic Pelvic Pain

A Pilot Study to Assess the Feasibility of a Randomized Control Trial Employing a Single-arm Intervention, at a Single Institution, to Study the Effects of Combined Self-induced Therapeutic Tremors Plus Mindfulness on Symptoms of Chronic Pelvic Pain.

To collect pilot data and assess the feasibility of a trial employing a single-arm intervention to study the effects of combined self-induced therapeutic tremors plus mindfulness on symptoms of chronic pelvic pain among women diagnosed with chronic pelvic pain.

Study Overview

Detailed Description

The estimated prevalence of chronic pelvic pain among women is 2-24%. The etiology of chronic pelvic pain is multifactorial making it very difficult to manage clinically. Evidenced-based therapies are limited and a multidisciplinary approach, including complementary and alternative medicine, to treat women with chronic pelvic pain may be the best approach. This study assess the feasibility of conducting randomized controlled trial with a single arm intervention to treat symptoms of chronic pelvis pain among women diagnosed with chronic pelvic pain. The intervention will consist of a novel combined alternative therapy intervention among women with chronic pelvic pain (self-induced therapeutic tremor plus mindfulness). This is a clinically significant project as lifestyle interventions to treat chronic pelvic pain are urgently needed, given the prevalence and the healthcare costs associated with chronic pelvic pain.

Study Objective: The primary purpose of this project is to collect pilot data and assess the feasibility of a single arm intervention trial to improve symptoms of CPP among women diagnosed with CPP.

Intervention Arm - Combined Alternative Therapy: The novel combined alternative therapy that will be studied consists of self-induced therapeutic tremors (SITT) plus mindfulness. SITT is the intentional induction of the body's innate tremor mechanism to treat hyperarousal and muscle tension, which is characteristic of CPP. SITTs are thought to restore somatic and autonomic nervous system homeostasis, by discharging sympathetic arousal and down-regulating the autonomic nervous system. Previous work has shown that mindfulness training may improve symptoms of CPP, however there are no studies investigating the impact that the combination of mindfulness coupled with SITTs may have on the symptoms of CPP.

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Tennessee
      • Knoxville, Tennessee, United States, 37920
        • The University of Tennessee Graduate School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Women
  • Age >18
  • Physical requirements: be able to complete the intervention sessions
  • Not seeking other therapeutic modalities, such as acupuncture, PT, during study duration
  • Free from surgery for >3 months
  • being treated clinically for chronic pelvic pain and related conditions
  • CPP of 6 months or more (to be considered chronic)
  • Availability to commit to the 4-week intervention (two 60-minute sessions per week at a specified time, for 4 weeks)
  • Internet access and consistent access to phone/email/text communication

Exclusion Criteria:

  • Pregnancy
  • Illicit substance use (e.g. cocaine, methamphetamines, heroin, street drugs) - marijuana and CBD oil and related supplements will be considered on a case-by-case basis by the principal investigators
  • Current psychiatric illness/social situation that would limit compliance with study requirements, as determined by the principal investigators

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Self-induced therapeutic tremor (SITT) combined with mindfulness

This arm will consist of self-induced therapeutic tremor (SITT) training combined with mindfulness training that is performed during a 60 minute session, 2 times per week, for 4 weeks.

Self-induced therapeutic tremor (SITT) combined with mindfulness: SITT is a way to reduce stress by turning on a natural shaking response. This can calm the participant's body. It involves doing simple exercises. During SITT muscles will gently shake, and release built up stress. This shaking of muscles lets the participant's body physically let go of tension and stress. Mindfulness is the ability to be fully present in a moment so that the participant can focus on what the participant is sensing and feeling in the moment. It involves the acceptance of thoughts and feelings without judging them. Practicing mindfulness involves breathing methods, guided imagery, and other practices to relax the body and mind, help reduce stress, and not be overwhelmed.

SITT is a way to reduce stress by turning on a natural shaking response. This can calm the participant's body. It involves doing simple exercises. The muscles will gently shake, and release built up stress. This shaking of the muscles lets the participant's body physically let go of tension and stress.

Mindfulness is the ability to be fully present in a moment. This allows focus on what the participant is sensing and feeling in the moment. It involves the acceptance of thoughts and feelings without judging them.

Practicing mindfulness involves breathing methods, guided imagery, and other practices to relax the body and mind, help reduce stress, and not be overwhelmed by what's going on around the participant.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility of the pilot trial
Time Frame: This will be assessed at the completion of the study, approximately 1-1.5 years after the study start.
To determine feasibility, the investigators will assess if it is possible to recruit, enroll, and have complete follow-up with participants. If the recruitment goal is met and 80% compliance with study visit attendance is achieved, the trial will be classified as feasible (yes/no classification).
This will be assessed at the completion of the study, approximately 1-1.5 years after the study start.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Physical Function
Time Frame: Pre- Program, Immediately Post-Program, and 1 Month Follow Up

PROMIS-29 Profile v2.0 Questionnaire will be used to assess the domain of Physical Function. This domain is assessed with 4 questions. Each question has 5 response options ranging in value from 1 to 5. To find the total raw score, the values of all 4 questions are summed. The lowest value is 4 and the highest value is 20. These total raw scores are converted into T-scores using the appropriate tables in the appropriate appendix in the "PROMIS ADULT PROFILE INSTRUMENTS SCORING MANUAL." The T-score rescales the raw score into a standardized T-score with a mean of 50 and a standard deviation (SD) of 10. A higher score represents more of this concept being measured. For this domain specifically, a higher score is a better outcome.

The change in T-score for this domain, across time, is assessed using repeated measures ANOVA.

Pre- Program, Immediately Post-Program, and 1 Month Follow Up
Change in Anxiety
Time Frame: Pre- Program, Immediately Post-Program, and 1 Month Follow Up

PROMIS-29 Profile v2.0 Questionnaire will be used to assess the domain of Anxiety. This domain is assessed with 4 questions. Each question has 5 response options ranging in value from 1 to 5. To find the total raw score, the values of all 4 questions are summed. The lowest value is 4 and the highest value is 20. These total raw scores are converted into T-scores using the appropriate tables in the appropriate appendix in the "PROMIS ADULT PROFILE INSTRUMENTS SCORING MANUAL." The T-score rescales the raw score into a standardized T-score with a mean of 50 and a standard deviation (SD) of 10. A higher score represents more of this concept being measured. For this domain specifically, a higher score is a worse outcome.

The change in T-score for this domain, across time, is assessed using repeated measures ANOVA.

Pre- Program, Immediately Post-Program, and 1 Month Follow Up
Change in Depression
Time Frame: Pre- Program, Immediately Post-Program, and 1 Month Follow Up

PROMIS-29 Profile v2.0 Questionnaire will be used to assess the domain of Depression. This domain is assessed with 4 questions. Each question has 5 response options ranging in value from 1 to 5. To find the total raw score, the values of all 4 questions are summed. The lowest value is 4 and the highest value is 20. These total raw scores are converted into T-scores using the appropriate tables in the appropriate appendix in the "PROMIS ADULT PROFILE INSTRUMENTS SCORING MANUAL." The T-score rescales the raw score into a standardized T-score with a mean of 50 and a standard deviation (SD) of 10. A higher score represents more of this concept being measured. For this domain specifically, a higher score is a worse outcome.

The change in T-score for this domain, across time, is assessed using repeated measures ANOVA.

Pre- Program, Immediately Post-Program, and 1 Month Follow Up
Change in Fatigue
Time Frame: Pre- Program, Immediately Post-Program, and 1 Month Follow Up

PROMIS-29 Profile v2.0 Questionnaire will be used to assess the domain of Fatigue. This domain is assessed with 4 questions. Each question has 5 response options ranging in value from 1 to 5. To find the total raw score, the values of all 4 questions are summed. The lowest value is 4 and the highest value is 20. These total raw scores are converted into T-scores using the appropriate tables in the appropriate appendix in the "PROMIS ADULT PROFILE INSTRUMENTS SCORING MANUAL." The T-score rescales the raw score into a standardized T-score with a mean of 50 and a standard deviation (SD) of 10. A higher score represents more of this concept being measured. For this domain specifically, a higher score is a worse outcome.

The change in T-score for this domain, across time, is assessed using repeated measures ANOVA.

Pre- Program, Immediately Post-Program, and 1 Month Follow Up
Change in Sleep Disturbance
Time Frame: Pre- Program, Immediately Post-Program, and 1 Month Follow Up

PROMIS-29 Profile v2.0 Questionnaire will be used to assess the domain of Sleep Disturbance. This domain is assessed with 4 questions. Each question has 5 response options ranging in value from 1 to 5. To find the total raw score, the values of all 4 questions are summed. The lowest value is 4 and the highest value is 20. These total raw scores are converted into T-scores using the appropriate tables in the appropriate appendix in the "PROMIS ADULT PROFILE INSTRUMENTS SCORING MANUAL." The T-score rescales the raw score into a standardized T-score with a mean of 50 and a standard deviation (SD) of 10. A higher score represents more of this concept being measured. For this domain specifically, a higher score is a worse outcome.

The change in T-score for this domain, across time, is assessed using repeated measures ANOVA.

Pre- Program, Immediately Post-Program, and 1 Month Follow Up
Change in Ability to Participant in Social Roles and Activities
Time Frame: Pre- Program, Immediately Post-Program, and 1 Month Follow Up

PROMIS-29 Profile v2.0 Questionnaire will be used to assess the domain of Ability to Participate in Social Roles and Activities. This domain is assessed with 4 questions. Each question has 5 response options ranging in value from 1 to 5. To find the total raw score, the values of all 4 questions are summed. The lowest value is 4 and the highest value is 20. These total raw scores are converted into T-scores using the appropriate tables in the appropriate appendix in the "PROMIS ADULT PROFILE INSTRUMENTS SCORING MANUAL." The T-score rescales the raw score into a standardized T-score with a mean of 50 and a standard deviation (SD) of 10. A higher score represents more of this concept being measured. For this domain specifically, a higher score is a better outcome.

The change in T-score for this domain, across time, is assessed using repeated measures ANOVA.

Pre- Program, Immediately Post-Program, and 1 Month Follow Up
Change in Pain Intensity
Time Frame: Pre- Program, Immediately Post-Program, and 1 Month Follow Up

PROMIS-29 Profile v2.0 Questionnaire will be used to assess the domain of Pain Intensity. This domain is assessed with 4 questions. Each question has 5 response options ranging in value from 1 to 5. To find the total raw score, the values of all 4 questions are summed. The lowest value is 4 and the highest value is 20. These total raw scores are converted into T-scores using the appropriate tables in the appropriate appendix in the "PROMIS ADULT PROFILE INSTRUMENTS SCORING MANUAL." The T-score rescales the raw score into a standardized T-score with a mean of 50 and a standard deviation (SD) of 10. A higher score represents more of this concept being measured. For this domain specifically, a higher score is a worse outcome.

The change in T-score for this domain, across time, is assessed using repeated measures ANOVA.

Pre- Program, Immediately Post-Program, and 1 Month Follow Up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 12, 2021

Primary Completion (Actual)

April 29, 2022

Study Completion (Actual)

May 30, 2022

Study Registration Dates

First Submitted

September 7, 2021

First Submitted That Met QC Criteria

July 18, 2022

First Posted (Actual)

July 20, 2022

Study Record Updates

Last Update Posted (Actual)

July 20, 2022

Last Update Submitted That Met QC Criteria

July 18, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 4818

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pelvic Pain

3
Subscribe